Immunovant, Inc. · NASDAQ:IMVT
Venker Eric sold 3,506 Immunovant, Inc. shares (Form 4)
Traded Oct 1 to Oct 2, 2026 · Filed Oct 5, 2026
From Oct 1 to Oct 2, 2026, Venker Eric (Director, Chief Executive Officer) sold 3,506 Immunovant, Inc. shares at US$34.11 for US$120K, leaving 257,075 shares. Filed Oct 5, 2026 (Form 4).
- Sold
- 3,506 shares
- Price
- US$34.11
- Value
- US$120K
- Holding after
- 257,075 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Option exercise | 92,187 | US$14.46 | 346,467 | Direct |
| Oct 1, 2026 | Common Stock | Disposition | 85,886 | US$33.65 | 260,581 | Direct |
| Oct 2, 2026 | Common Stock | Sale | 3,506 | US$34.11 | 257,075 | Direct |
Source
Related
- Immunovant, Inc.
- Venker Eric
- Immunovant, Inc. shareholders
- Form 4 · Venker Eric · Jul 6, 2026
- Form 4 · Venker Eric · Apr 9, 2026
- Form 4 · Venker Eric · Apr 3, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Pande Atul · Aug 28, 2026